Core Laboratories (CLB) Misses Q4 Earnings and Revenue Estimates

Core Laboratories Earnings Summary - Core Laboratories reported quarterly earnings of $0.22 per share, missing the Zacks Consensus Estimate of $0.23 per share, but showing an increase from $0.19 per share a year ago, resulting in an earnings surprise of -4.35% [1] - The company posted revenues of $129.24 million for the quarter ended December 2024, which was 1.27% below the Zacks Consensus Estimate, but slightly above the year-ago revenues of $128.21 million [2] - Over the last four quarters, Core Laboratories has surpassed consensus EPS estimates two times and has topped consensus revenue estimates two times [2] Stock Performance and Outlook - Core Laboratories shares have increased approximately 7.1% since the beginning of the year, outperforming the S&P 500's gain of 3.2% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The estimate revisions trend for Core Laboratories is currently unfavorable, leading to a Zacks Rank 4 (Sell), indicating expected underperformance in the near future [6] Future Earnings Estimates - The current consensus EPS estimate for the upcoming quarter is $0.23 on revenues of $131.62 million, and for the current fiscal year, it is $1.02 on revenues of $542.45 million [7] - The outlook for the Oil and Gas - Field Services industry, where Core Laboratories operates, is currently in the bottom 16% of Zacks industries, which may impact stock performance [8]